IL125789A - USE OF A DELETION VARIANT HUMAN t-PA PROTEIN IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF VASCULAR DISEASES - Google Patents

USE OF A DELETION VARIANT HUMAN t-PA PROTEIN IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF VASCULAR DISEASES

Info

Publication number
IL125789A
IL125789A IL12578988A IL12578988A IL125789A IL 125789 A IL125789 A IL 125789A IL 12578988 A IL12578988 A IL 12578988A IL 12578988 A IL12578988 A IL 12578988A IL 125789 A IL125789 A IL 125789A
Authority
IL
Israel
Prior art keywords
medicament
protein
preparation
treatment
vascular diseases
Prior art date
Application number
IL12578988A
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/188,237 external-priority patent/US4935237A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL125789A publication Critical patent/IL125789A/en

Links

IL12578988A 1987-06-30 1988-06-28 USE OF A DELETION VARIANT HUMAN t-PA PROTEIN IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF VASCULAR DISEASES IL125789A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6844887A 1987-06-30 1987-06-30
US17097088A 1988-03-21 1988-03-21
US07/188,237 US4935237A (en) 1988-03-21 1988-04-29 Processes for the preparation of t-PA mutants
IL8688788A IL86887A (en) 1987-06-30 1988-06-28 METHODS OF PRODUCING PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS USEFUL IN THE TREATMENT OF VASCULAR DISEASE AND PROVIDING VARIANTS OF HUMAN PLASMINOGEN ACTIVATOR (t-PA) AND PHARMACEUTICAL COMPOSITIONS PREPARED BY SUCH METHODS

Publications (1)

Publication Number Publication Date
IL125789A true IL125789A (en) 2005-08-31

Family

ID=27452336

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12578988A IL125789A (en) 1987-06-30 1988-06-28 USE OF A DELETION VARIANT HUMAN t-PA PROTEIN IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF VASCULAR DISEASES
IL8688788A IL86887A (en) 1987-06-30 1988-06-28 METHODS OF PRODUCING PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS USEFUL IN THE TREATMENT OF VASCULAR DISEASE AND PROVIDING VARIANTS OF HUMAN PLASMINOGEN ACTIVATOR (t-PA) AND PHARMACEUTICAL COMPOSITIONS PREPARED BY SUCH METHODS

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL8688788A IL86887A (en) 1987-06-30 1988-06-28 METHODS OF PRODUCING PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS USEFUL IN THE TREATMENT OF VASCULAR DISEASE AND PROVIDING VARIANTS OF HUMAN PLASMINOGEN ACTIVATOR (t-PA) AND PHARMACEUTICAL COMPOSITIONS PREPARED BY SUCH METHODS

Country Status (1)

Country Link
IL (2) IL125789A (en)

Also Published As

Publication number Publication date
IL86887A0 (en) 1989-03-31
IL86887A (en) 2005-06-19

Similar Documents

Publication Publication Date Title
NZ228564A (en) Corticosteroid-containing skin care composition for use as moisturiser: preparation thereof
HU912266D0 (en) Process for the production of solid medical preparations with controlled portioning of the active agents for oral use
NZ266475A (en) Use of recombinant adenovirus of animal origin in making pharmaceutical composition
JPS6463596A (en) Novel peptide having activity inhibiting platelet coagulation and adaptation thereof to medical treatment
EP0388434A4 (en) Differential delivery of therapeutic agents across the blood brain barrier
GB2107589B (en) Anhydrous composition containing anthralin or a derivative for use in the treatment of skin diseases
EP0506893A4 (en) Diagnosis and treatment of diseases
AU2690684A (en) Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
EP0324802A4 (en) Method for the treatment of body tissues and the administration of drugs thereto
AR243384A1 (en) Use of antigenic products for prophylaxis or therapy of disorders or diseases in the human and animal digestive systems
DE3570363D1 (en) Amino acid solution-containing drug for the treatment of cancerous diseases and preparation process thereof
AU7670687A (en) Improvements in or relating to the treatment of occlusive vascular diseases
PT84755A (en) Process for the preparation of a pharmaceutical composition for the treatment of skin diseases
EP0294538A3 (en) Use of nigericin in the treatment of viral diseases
IL125789A (en) USE OF A DELETION VARIANT HUMAN t-PA PROTEIN IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF VASCULAR DISEASES
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
GB8710664D0 (en) Self-administration of ocular treatment materials
GB8806116D0 (en) Treatment of skin diseases
AU2395288A (en) Metoprolol in the treatment and prophylaxis of heart disease
IL81361A0 (en) Pharmaceutical preparation for treatment of hyperacidity in body fluids
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
IE872117L (en) Treatment of occlusive vascular diseases
IE883282L (en) Treatment of bone diseases
IE871907L (en) "methods for treatment of sundamaged human skin with¹retinoids"
AU605580C (en) Aerosolization of protein therapeutic agent

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
EXP Patent expired